-Optimus
Multimodal by design, Multi-scale by nature, M-Optimus by Bioptimus.
Predict Gene Expression
Use M-Optimus to find new molecular signatures:
Explore your data within the context of thousands of other similar patients. Or fine tune the foundation model, predicting gene expression from multimodal embeddings of H&E slides, routine sequencing and spatial transcriptomics. Use M-Optimus as a deep mining tool to identify new connections and new molecular signatures.

Predict patient stratification and outcomes
Model patients for trial in silico:
Leverage M-Optimus to predict outcomes like Objective Response Rate (ORR) and Progression-Free Survival (PFS).
Power synthetic clinical trial arms, providing a clearer picture of patient profiles that are likely to respond to novel therapeutics.
Predict Drug Targets
M-Optimus fills in the missing information:
By predicting gene expression directly from rountine H&E, M-Optimus lowers the thresholds to patient qualification. And for the drug discovery and early clinical researchers, M-Optimus explains the biological mechanisms that underpin response.

Understand Complex Biology
M-Optimus augments routine data to power research:
With a foundation model built using an unprecedented scale of patient data, you can identify cohorts that are more likely to respond, even in the absence of a complete biological landscape from each patient. The result? Patients can receive more effective therapy, earlier.

Built to facilitate novel insights and better decision‑making
M-Optimus integrates disparate biological modalities into a unified embedding space through a proprietary neural architecture. This backbone enables the rapid deployment of specialized downstream models, allowing teams to achieve high-accuracy predictions with minimal data.
